Table 3.

Association between ATP2B1 gene polymorphism and chronic kidney disease patients

ATP2B1	Cases	Controls	OR	95% CI	P
GG	21	33	Reference	-	-
AG	20	11	2.7	1.1-6.6	0.02*
AA	9	6	2.4	0.7-7.9	0.12
GG versus AG + AA	29	17	2.8	1.2-6.3	0.01*
G	62	77	Reference	-	-
A	38	23	2.0	1.1-3.8	0.02*

*P < 0.05 Statistically significant; *Moderately significant (P: 0.01<P≤0.05). OR: Odds ratio; CI: Confidence interval